Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
News
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Media coverage
Investor news
News archive
Posts in: nutraceuticals (2)
press release
investor
nutraceuticals
video
science
eXoZymes biomanufacturing breakthrough: From concept to gram-scale NCT in only 5 months
July 22, 2025
press release
investor
nutraceuticals
medicine
science
eXoZymes selected as core industry partner in $9M NSF-funded initiative to advance modular cell-free biomanufacturing
June 26, 2025
press release
investor
nutraceuticals
medicine
science
eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health
May 6, 2025
Previous page
Page 2 of 2
Next page